|07:00 17-May-2013||VENN||Innovation division launch & co-development||RNS||0.00%|
|08:36 07-May-2013||VENN||Holding(s) in Company||RNS||-1.90%|
|07:09 26-Apr-2013||VENN||Project wins||RNS||0.00%|
|07:00 09-Apr-2013||VENN||Senior Management Appointments||RNS||-0.32%|
|07:00 14-Mar-2013||VENN||Board Appointment||RNS||0.00%|
|13:19 05-Mar-2013||VENN||Holding(s) in Company||RNS||+0.95%|
|12:47 28-Feb-2013||VENN||Director/PDMR Shareholding||RNS||+1.27%|
|09:49 21-Feb-2013||VENN||Director/PDMR Shareholding||RNS||+1.94%|
|07:00 07-Feb-2013||VENN||Venn Life Sciences expands into Russia||RNS||+2.68%|
|07:00 14-Dec-2012||VENN||Admission to trading on AIM||RNS||-2.86%|
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
You will be redirected in five seconds